首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Fungal protein MGL-1304 in sweat is an allergen for atopic dermatitis patients
【24h】

Fungal protein MGL-1304 in sweat is an allergen for atopic dermatitis patients

机译:汗液中的真菌蛋白MGL-1304是过敏性皮炎患者的过敏原

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Sweat is a major aggravating factor of atopic dermatitis (AD) and approximately 80% of patients with AD show type I hypersensitivity against sweat. Objective: To identify and characterize an antigen in sweat that induces histamine release from basophils of patients with AD. Methods: Basophil histamine-releasing activity in sweat was purified by a combination of chromatographies, and proteins were analyzed with mass spectrometry. Recombinant proteins of the sweat antigen were generated, and their biological characteristics were studied by immunoblots, histamine release tests, and neutralization assays. Results: We identified a fungal protein, MGL-1304, derived from Malassezia globosa (M globosa) in the purified sweat antigen. Recombinant MGL-1304 induced histamine release from basophils of most of the patients with AD, in accordance with the semi-purified sweat antigen. Moreover, recombinant MGL-1304 abolished the binding of serum IgE of patients with AD to the semi-purified sweat antigen, or vice versa in immunoblot analysis, and attenuated the sensitization of RBL-48 mast cells expressing human FcéRI by serum IgE. Studies of truncated mutants of MGL-1304 indicated that IgE of patients with AD recognized the conformational structure of MGL-1304 rather than short peptide sequences. Western blot analysis of the whole lysate, the culture supernatant of M globosa, and the semi-purified sweat antigen showed that MGL-1304 was produced as a minor immunological antigen of M globosa with posttranslational modification, cleaved, and secreted as a 17-kDa major histamine-releasing sweat antigen. Conclusion: MGL-1304 is a major allergen in human sweat and could cause type I allergy in patients with AD.
机译:背景:汗水是特应性皮炎(AD)的主要加重因素,大约80%的AD患者表现出对汗水的I型超敏反应。目的:鉴定和表征汗液中一种抗原,该抗原可诱导AD患者嗜碱性粒细胞释放组胺。方法:结合色谱法纯化汗液中嗜碱性粒细胞的组胺释放活性,并通过质谱分析蛋白质。产生了汗液抗原的重组蛋白,并通过免疫印迹,组胺释放测试和中和分析研究了它们的生物学特性。结果:我们在纯化的汗液抗原中鉴定了一种源自球形小球藻(Malassezia globosa(M globosa))的真菌蛋白MGL-1304。根据半纯化的汗液抗原,重组MGL-1304诱导大多数AD患者嗜碱性粒细胞释放组胺。此外,在免疫印迹分析中,重组MGL-1304消除了AD患者血清IgE与半纯化汗液抗原的结合,反之亦然,并且减弱了血清IgE对表达人FcéRI的RBL-48肥大细胞的敏感性。 MGL-1304突变体的研究表明,AD患者的IgE识别MGL-1304的构象结构,而不是短肽序列。对整个裂解物,球状球菌的培养上清液和半纯化的汗液抗原的蛋白质印迹分析表明,MGL-1304是翻译后修饰的M球状球菌的次要免疫抗原,裂解后分泌为17 kDa。主要的组胺释放汗液抗原。结论:MGL-1304是人类汗液中的主要过敏原,可引起AD患者的I型过敏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号